CLDI: Multiplikator P/S Calidi Bio
High biomaterial costs and the risk of secondary offerings are putting pressure on Calidi Biotherapeutics (CLDI) share prices. The price-to-sales ratio trend visualizes these fluctuations, where forms the current metric value. A lack of operating cash flow coupled with inertial capital is hindering growth, yet the company's status as an innovator in stem cell drug delivery strengthens the authority of Calidi Biotherapeutics (CLDI) in the fight against oncology.
Rincian analitis perusahaan Calidi Biotherapeutics (CLDI)
- rega pasar lan target rega analis:
- informasi kapitalisasi pasar:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Rasio Utang marang Ekuitas Calidi Biotherapeutics|CLDI - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal calidibio.com|CLDI - Gunggung utang perusahaan|Rasio utang marang aset resik Calidi Bio|CLDI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Calidi Biotherapeutics|Koefisien jangkoan perantara calidibio.com
- rincian asil keuangan lan kelipatan valuasi:
CLDI - Bathi resik perusahaan|Bathi resik sing dikarepake Calidi Biotherapeutics|CLDI - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep calidibio.com|CLDI - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Calidi Bio|CLDI - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Calidi Biotherapeutics|CLDI - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan calidibio.com|CLDI - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Calidi Biotherapeutics
- rincian pendapatan lan dodolan emiten:
Ringkesan analitik perusahaan:Calidi Biotherapeutics Inc., CLDI
The P/S ratio compares a business's market value to its annual revenue, allowing for an assessment of the premium paid per unit of generated income. For Calidi Biotherapeutics (CLDI), which focuses on costly oncology research without stable sales, this metric serves as an indicator of speculative expectations, making the price-to-sales multiple a critical marker of capital overvaluation risk.
Perusahaan pesaing
Kapitalisasi marang pendapatan beigene.com ONC|Multiplikator P/S HALO (Halozyme)|Multiplikator P/S Revolution Medicines Inc RVMD|AAPG - Rasio rega marang pendapatan|CGON: Rasio rega marang pendapatan|URGN: Multiplikator P/S|BCAX - Koefisien rega marang pendapatan|PSNL (Personalis) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan ERAS (Erasca Inc)|Multiplikator P/S DCTH|Koefisien rega marang pendapatan Y-mAbs Corp|Aura Biosciences, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan CADL|Accuray - Multiplikator P/S|SLS: Rasio rega marang pendapatan|ACTU: Multiplikator P/S|CTOR - Koefisien rega marang pendapatan|Rasio rega marang pendapatan TuHURA Biosciences Inc.|Rega marang dodolan protaratx.com TARA|Kapitalisasi marang pendapatan FATE (Fate Therapeutics)|Kapitalisasi marang volume dodolan WHWK|Multiplikator P/S TCRX (TScan Therapeutics, Inc.)|Rasio kapitalisasi pasar marang pendapatan CSBR|XBiotech USA - Multiplikator P/S|Rega marang dodolan CEL-SCI Corporation|OS Therapies (OSTX) - Rasio rega marang pendapatan|radiopharmtheranostics.com - Rasio kapitalisasi pasar marang pendapatan|ARTV (Artiva Biotherapeutics Inc.) - Multiplikator P/S|Multiplikator P/S Adlai Nortye Limited|Rasio rega marang pendapatan Veru Inc. (VERU)|TPST: Rasio rega marang dodolan|Multiplikator P/S XLO (Xilio Therapeutics)|Renovaro Biosciences (RENB) - Rega marang dodolan|MURA: Kapitalisasi marang pendapatan|KAPA - Multiplikator P/S|OKUR (onkuretherapeutics.com) - Kapitalisasi marang pendapatan|GDTC: Kapitalisasi marang volume dodolan|CRIS (Curis Inc.) - Multiplikator P/S|Apollomics Corp (APLM) - Koefisien rega marang pendapatan|Multiplikator P/S THAR|Kapitalisasi marang pendapatan advanbiomed.com ADVB|Rasio rega marang pendapatan Genprex, Inc. GNPX|Koefisien rega marang pendapatan sunshinebiopharma.com (SBFM)|Xenetic Bio - Multiplikator P/S|Salarius Pharmaceuticals Inc (SLRX) - Kapitalisasi marang pendapatan|Purple Biotech Corp (PPBT) - Rasio rega marang pendapatan|AONC (American Oncology Network, Inc.) - Rasio rega marang pendapatan|BGNE (BeiGene, Ltd.) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan CKPT (checkpointtx.com)|Multiplikator P/S ELEV|Koefisien rega marang pendapatan icadmed.com|Multiplikator P/S IKNA (Ikena Oncology)|NTBL - Kapitalisasi marang pendapatan|Viracta - Multiplikator P/S|MOR - Multiplikator P/S|NAYA Biosciences Inc. (NAYA) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan AAPGV
